SAN DIEGO, Jan. 09, 2017 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in Pennsylvania on behalf of certain purchasers of units of StoneMor Partners L.P. (NYSE:STON) over alleged Securities Laws Violations by StoneMor Partners L.P..
Investors who purchased a significant amount of StoneMor Partners L.P. (NYSE:STON) units have certain options and for certain investors there are short and strict deadlines running. Deadline: January 20, 2017. NYSE:STON investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff alleges that the defendants StoneMor Partners L.P. and certain of its executive officers made false and/or misleading statements and/or failed to disclose that the Company's reported non-GAAP financial metrics were materially misleading and concealed the truth about the Company's actual financial condition, and that the primary purpose of the Company's regular debt and equity offerings was to pay distributions to unitholders rather than to pay down indebtedness under the Company's revolving credit facility as publicly stated.
The complaint further alleges that, as a result of the foregoing, StoneMor's statements about its business, operations and prospects were false and misleading and/or lacked a reasonable basis at all relevant times.
Those who purchased StoneMor Partners L.P. (NYSE:STON) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 



